Skip to main content
Equibles

Knoll Capital Management, LLC

Position in OCUL — Ocular Therapeutix, Inc

CIK 1325083 MIAMI, FL
Back to OCUL Full portfolio

Position in OCUL

as of Jun 30, 2026 · filed Sep 10, 2026
Position Value
$11,296,928
+$6,211,540 QoQ
Shares Held
1,150,400
+91.6% QoQ
Ownership
0.524%
of shares outstanding
% of Portfolio
6.48%
of 13F equity value
Holder Rank
#31
of 260 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Derivatives in OCUL

reported options exposure · as of Jun 30, 2023
CallValue
$494,328
CallShares
95,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Knoll Capital Management, LLC holds $72,284,754 across 10 Biotechnology names. OCUL ranks #3 (15.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MGTX
MeiraGTx Holdings plc
 1,250,000 $16,887,500
2 ALDX
Aldeyra Therapeutics, Inc.
 5,475,516 $11,662,849
3 OCUL
Ocular Therapeutix, Inc
This page 		1,150,400 $11,296,928
4 ENTX
Entera Bio Ltd.
 5,881,879 $10,410,925
5 NUVB
Nuvation Bio Inc.
 1,598,591 $9,079,996
6 ELTX
Elicio Therapeutics, Inc.
 1,211,957 $4,738,751
7 ABVX
Abivax S.A.
 35,000 $4,664,100
8 ABEO
Abeona Therapeutics Inc.
 485,515 $3,000,482

All Filings in OCUL

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,296,928 1,150,400
2026-03-31 $5,085,388 600,400
2025-12-31 $7,288,856 600,400
2025-09-30 $7,018,676 600,400
2025-06-30 $5,571,712 600,400
2025-03-31 $4,400,932 600,400
2024-12-31 $5,127,416 600,400
2024-09-30 $5,223,480 600,400
2024-06-30 $1,370,736 200,400
2024-03-31 $1,823,640 200,400
2023-12-31 $893,784 200,400
2023-09-30 $1,256 400
2023-06-30 $1,032,000 200,000
2023-06-30 $494,328 95,800
2023-03-31 $1,054,000 200,000
2023-03-31 $504,866 95,800